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Abstract
The association between alcohol intake and cutaneous squamous cell carcinoma (cSCC) is unclear. 
We studied the association between alcohol intake and incident invasive cSCC in three cohorts of 
women and men with repeated assessments of alcohol intake in the US. Information on alcohol 
intake was collected repeatedly during follow-up. Cumulative average of alcohol intakes was used. 
Multivariable Cox proportional hazards models with time-dependent exposure were used to 
estimate relative risks (RR) and 95% confidence intervals, followed by a meta-analysis. During a 
follow-up of 4,234,416 person-years, 2,938 cSCC were identified. Alcohol intake was associated 
with an increased risk of cSCC with a dose-response relationship. Each additional drink (12.8 
gram of alcohol) per day was associated with a 22% increased risk of cSCC (RR 1.22, 95% 
confidence interval: 1.13 to 1.31). White wine consumption of ≥5 times/wk was associated with an 
increased risk of cSCC (RR 1.31, 95% confidence interval: 1.09 to 1.59). We found no increased 
risk of cSCC with other alcoholic beverages. The population attributable risk associated with 
alcohol intake of ≥20 grams/d was 3% of cSCCs. In conclusion, alcohol intake was associated 
with an elevated risk of cSCC. Among alcoholic beverages, white wine was associated with cSCC.
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INTRODUCTION
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin 
cancer and its incidence is increasing rapidly. (1, 2) The most important risk factor for cSCC 
is high level of cumulative ultraviolet light (UV) exposure. (3, 4) Other risk factors include 
age, male gender, skin phototype, light or red hair colour, and immunosuppressant use. (2, 5, 
6) Although seldom fatal with a metastatic rate up to 5% of the cases (7), cSCC is associated 
with considerable burden of illness. (8, 9) It is therefore important to identify patients with a 
high risk of developing cSCC in order to minimize the treatment costs and improve primary 
and secondary prevention of cSCC.
The role of alcohol intake on the occurrence of cSCC is controversial (8) and has not been 
investigated in large epidemiological studies. Alcohol use has been associated with an 
increased risk of basal cell carcinoma (BCC) (10-12), the most common form of skin cancer. 
However, the cell of origin and molecular pathways of BCC and cSCC are different (13, 14) 
and the extent to which alcohol contributes to non-melanoma skin cancer risk may therefore 
also differ. We therefore evaluated the association between alcohol intake and risk of cSCC 
in three large cohorts of US women and men with repeated assessments of alcohol intake.
MATERIAL AND METHODS
Study population
The Nurses’ Health Study (NHS) is a prospective cohort study in which 121,700 married, 
registered, female nurses of 30-55 years old were enrolled in 1976. The Nurses’ Health 
Study II (NHS II) was established in 1989 when 116,686 female nurses 25-42 years old 
were enrolled. The Health Professionals’ Follow-up Study (HPFS) was established in 1986 
with 51,529 men 40-75 years employed in a health profession. In all cohorts, participants 
completed self-administered, mailed questionnaires biennially inquiring about disease 
history and lifestyle habits with response rates generally exceeding 90%. All studies were 
approved by the Institutional Review Board of Brigham and Women's Hospital (Boston, 
MA, USA).
Assessment of alcohol intake
To assess dietary intake including alcohol intake, a food-frequency questionnaire that 
inquired about the average use of food and beverages during the past year was used. The 
dietary questionnaires including alcohol intake were completed in 1980, 1984, 1986, 1990, 
1994, 1998, 2002 and 2006 for NHS, in 1991, 1995, 1999, 2003, 2007 for NHS II, and in 
1986, 1990, 1994, 1998, 2002 and 2006 for HPFS. On the questionnaires, participants were 
asked how many times on average during the previous year they had consumed each 
alcoholic beverage: light beer, non-light beer, white wine, red wine, and liquor. The 
participants could choose from 9 frequency responses (never/almost never, 1-3 per month, 1 
per week, 2-4 per week, 5-6 per week, 1 per day, 2-3 per day, 4-5 per day and ≥6 per day). 
For our analyses of individual alcoholic beverages, the categories were merged as follows: 
none, 1-3 per month, 1 per week, 2-4 per week and ≥5 per week. The total alcohol intake 
was assessed by summing up the alcohol content for a specific type of each beverage. Total 
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amount of alcohol consumed was estimated at 12.8 g for a glass, bottle, or a can of beer (12 
fl oz or 360 ml), 11 g for a glass of wine (4 fl oz or 120 ml), and 14 g for a shot of liquor 
(1.5 fl oz or 45 ml). Cumulative average of alcohol intakes was calculated. For example, 
alcohol intake in 1980 was used for analyses of cSCC diagnosed from 1980 through 1984, 
and the average alcohol intake through 1980 to 1984 was used for analyses of colon cancer 
diagnosed from 1984 through 1986 and so on in the NHS.The total average alcohol intake 
was divided into the following categories of grams per day: None, 0-4.9, 5-9.9, 10-19.9, and 
≥20 as well as analysed as a continuous variable. When translating the total average alcohol 
intake back into daily drinks, one drink was defined as 12.8 g of alcohol (median amount of 
alcohol in beer, wine, and liquor). The dietary questionnaire has been validated previously 
against 1-week diet records. (15, 16) The observed correlation between the questionnaire 
and the diet record was ≥0.8 for different alcoholic beverages.
Identification of cases of cutaneous squamous cell carcinoma
Participants in the cohorts reported new cases of invasive cSCC and cSCC in situ biennially 
through 2008 in NHS, 2009 in NHS II, and 2008 in HPFS. All events were verified from 
primary histopathology reports by study physicians. Only the incident (first) cSCC was 
included in this analysis. Invasive and in situ cSCC were analysed as separate outcomes 
because we had no a priori knowledge on whether the carcinogenicity of ethanol and its 
metabolites differ between invasive and in situ cSCC. cSCC of more sun exposed sites 
included tumors of the scalp, forehead, eyes, cheeks, nose, mouth, face, ears, neck, upper 
arms, elbows, foreams, hands, and fingers. cSCC of less sun exposed sites included tumors 
of the trunk, shoulders, thighs, legs, ankles, and feet.
Assessment of covariates
Data on known skin cancer risk factors were obtained from cohort questionnaires for all 
cohorts in the 1980s and 1990s. These risk factors include age, natural hair colour, mole 
count, average UVB flux at residence (17), skin reaction to sun exposure during childhood/
adolescence, the number of lifetime severe or blistering sunburns, family history of 
melanoma, smoking status and pack-years smoked (combined), body-mass index (kg/m2), 
caffeine intake and physical activity measured in metabolic equivalent hours per week. The 
time-dependent covariate information was updated with each questionnaire cycle or as 
available. In case of missing covariate information, information was carried over from 
previous questionnaire cycle.
Statistical analysis
Each participant contributed person-time from the date of the first questionnaire including 
information on alcohol intake to the date of diagnosis of first confirmed cSCC, report of any 
other cancer including other skin cancers or the end of follow-up. Those who were lost to 
follow-up were censored at the return date of the last questionnaire. Individuals with a prior 
history of any cancer were excluded from analysis. Additionally, because the cohorts were 
all greater than 95% Caucasian, non-white participants were excluded from the analysis. 
These included Asians, African-Americans, and Hispanics.
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We used Cox proportional hazards regression models with time-dependent covariates 
stratified by age and 2-year time intervals to estimate the relative risks (RR) and 95% 
confidence intervals of developing invasive or in situ cSCC across alcohol intake categories. 
Multivariable analyses were performed by adjusting for age (continuous variable), smoking 
(categorical: see text below), family history of melanoma (categorical), number of moles 
(categorical), natural hair colour (categorical), childhood/adolescent reaction to sun exposure 
(categorical), number of sunburns (categorical), body-mass index (categorical), physical 
activity measured by metabolic equivalent hours per week (categorical), UVB flux at 
residence (categorical) and caffeine intake (categorical). Multivariable analyses for type of 
alcoholic beverage were additionally adjusted for total alcohol intake (categorical) because 
we were interested in knowing whether other ingredients than ethanol in different beverages 
would influence the skin cancer risk. In order to examine possible confounding by smoking 
in detail, we constructed a categorical variable combining smoking status and the number of 
pack-years (pyrs) of smoking. The categories were as follows: no smoking, past smoking < 
10 pyrs, past smoking 10-19 pyrs, past smoking 20-39 pyrs, past smoking 40+ pyrs, past 
smoking unknown pyrs, current smoking <25 pyrs, current smoking 25-44 pyrs and current 
smoking 45+ pyrs/unknown. The categorization was determined a priori and based on 
number of pack-years with a reasonable number of participants in each category.
The meta-analyses of total average alcohol intake were performed using the data from 
multivariable models in all three cohorts during the follow-up. We tested the heterogeneity 
between studies and estimated the overall association from random effects. We tested the 
linear trend for one drink (12.8 gram alcohol) per day and estimated the dose-response trend 
between daily alcohol intake (grams per day) and cSCC in women and men separately.
We also evaluated the dose-response association between daily alcohol intake (grams per 
day) and cSCC in women and men separately using restricted cubic spline with knots at 5, 
10, 20, and 30 grams of alcohol per day.
We statistically tested the interaction between alcohol intake and the following variables: 
age, gender, smoking, BMI, number of severe sunburns, and caffeine intake.
Population attributable risk (PAR; %) was calculated based on the RR obtained from meta-
analyses using the following formula: 100*(Px*(RR-1))/(1+(Px*(RR-1))) where Px is the 
prevalence of alcohol use in the population at baseline.
All statistical analyses were conducted using Statistical Analysis System software (SAS, 
version 9.2; SAS Institute Inc, Cary, NC) and all P-values were calculated from 2-sided tests 
and considered significant if P < 0.05.
RESULTS
Among the 223,138 persons (174,998 women and 48,140 men) in the study cohorts, 2,938 
incident invasive cSCC and 1,590 incident cSCC in situ were identified during a follow-up 
of 4,234,416 person-years. The duration of follow-up was 19 years on average. A total of 
66,777 participants were excluded from the inception cohorts due to missing information on 
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alcohol intake or birth date, death before first dietary questionnaire, history of cancer, or 
because they were non-white.
Baseline characteristics of the participants in each study
At the baseline, 68% of the participants in NHS, 58% of the participants in NHS II, and 77% 
of the participants in HPFS (66% of the total study population) reported to have consumed 
alcohol in the past year (Table 1). Current and past smoking were positively correlated with 
alcohol intake and heavier drinkers were more likely to smoke than those consuming smaller 
amounts of alcohol. Physical activity, caffeine intake, and number of severe burns were also 
positively correlated with alcohol intake in all cohorts. Relative to their total alcohol intake, 
men were more likely to consume liquor and less likely to consume white wine than women 
(Supplementary Table 1). Younger women (NHSII) were more likely to consume beer and 
light beer and less likely to consume liquor than older women(NHS).
Total alcohol intake
After adjustment for other known risk factors for cSCC in a multivariable model, there was 
an increased risk for invasive cSCC in women and men who drank alcohol compared with 
abstainers (Table 2) and a highly significant dose-response relationship was observed across 
increasing alcohol intake categories in each cohort (all P trend ≤0.01) . When alcohol use 
was analysed as a continuous variable of 1 drink per day, the RRs were 1.27(95% CI 1.14 to 
1.40) for NHS, 1.31 (95% CI 1.07 to 1.61) for NHS II and 1.15 (95% CI 1.04 to 1.27) for 
HPFS. When the association was evaluated by body location of cSCC based on sun exposure 
level, the positive association was consistent across cSCC of more sun exposed sites (scalp, 
forehead, eyes, cheeks, nose, mouth, face, ears, neck, upper arms, elbows, foreams, hands, 
and fingers) vs. less sun exposed sites (trunk, shoulders, thighs, legs, ankles, feet); the RRs 
for 1 drink per day was 1.16 (1.07-1.26) for more sun- exposed sites and 1.33 (1.16-1.54) for 
less sun-exposed sites. For cSCC in situ, the positive trend was only significant in men (P 
trend=0.023, Supplementary Table 2).
The risk estimates for women appeared higher than those for men at the same alcohol intake 
category. For example, in men, the increased risk for invasive cSCC associated with alcohol 
intake was statistically significant only at the highest category of alcohol intake (RR 1.33; 
95% CI 1.11 to 1.60 for ≥20 grams per day) while a similar and statistically significant risk 
estimate was observed for women from the alcohol intake of 5.0-9.9 grams per day (RR 
1.35, 95% CI 1.15 to 1.58) with the RR for the highest intake category of ≥20 grams per day 
of 1.44 (95% CI1.19 to 1.73) (Supplementary Table 3). Our regression analyses with 
restricted cubic spline suggested a similar dose-response association for women and men 
(Figure 1). In women, there was a steep increase in risk on lower intake levels of up to 5 
grams per day after which the risk continued to increase slowly (non-linear relationship). In 
men, the risk increased in a linear manner as the daily alcohol dose increased.
In a meta-analysis of all three cohorts (women and men, Table 2 and Supplementary Table 
2), total alcohol intake was significantly associated with a higher risk for invasive cSCC and 
cSCC in situ. There was a significant dose-response relationship for both invasive cSCC and 
in situ cSCC. Each additional drink (12.8 gram of alcohol) per day was associated with 22% 
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increased risk of invasive cSCC (RR 1.22; 95% CI 1.13 to 1.31, P trend <0.0001) and 14% 
increased risk for cSCC in situ (RR 1.14, 95% CI 1.04 to 1.26, P trend=0.007). The pooled 
multivariable adjusted RR for those who drank more than 20 grams of alcohol per day was 
1.38 (1.21 to 1.57) for invasive cSCC and 1.28 (1.05 to 1.54) for cSCC in situ compared 
with abstainers. The PAR for the highest alcohol intake category of ≥20 grams per day was 
3.0% for invasive cSCC and 2.2% for cSCC in situ.
We statistically tested the interaction between alcohol intake and the following variables: 
age, gender, smoking, BMI, number of severe sunburns, and caffeine intake and found no 
significant interaction (data not shown).
Type of Alcoholic Beverage
The association between beverage type and invasive cSCC was analyzed in alcohol-adjusted 
multivariable models, thereby aiming to evaluate individual beverages independent of total 
alcohol intake. Consuming ≥ 5 drinks of white wine per week was significantly associated 
with a higher risk of invasive cSCC (RR 1.31, 1.09 to 1.59) in the meta-analysis of beverage 
type (Table 3) independent of its ethanol content. No other alcoholic beverages were 
statistically significantly associated with cSCC in a meta-analysis although intakes of light 
beer in NHS and NHSII and liquor in NHS were associated with elevated risk of cSCC. 
Individual alcoholic beverages were not associated with cSCC in situ (Supplementary Table 
4)
DISCUSSION
We conducted a large epidemiological study in three cohorts of US women and men and 
observed that alcohol intake was associated with an increased risk of invasive and in situ 
cSCC. There was a significant dose-response relationship between total alcohol intake and 
risk of both malignancies. These associations were independent of other known risk factors 
for cSCC, such as age, gender, skin phototype, and number of severe burns and consistent 
across body location of tumors based on sun exposure level. When examining the individual 
alcohol containing beverages, correcting for the total alcohol intake, only white wine 
consumption was significantly associated with an additional risk of cSCC.
A summary of the three previous studies on alcohol intake and cSCC is presented as a 
Supplementary Table 5. A recent Danish prospective cohort study with 198 cSCC cases 
found no convincing association between alcohol intake and cSCC. (12) Although the RR 
for alcohol use was above 1, the study lacked statistical power and the risk estimate was not 
statistically significant. An earlier study in transplant recipients from five European 
countries with 224 cSCC cases reported an inconsistent association between alcohol intake 
and cSCC. (18) The prevalence of alcohol consumption in controls in this study varied from 
22% (Germany) to 91% (France), which may explain the inconsistency as the power to study 
alcohol exposure might have been too low in some study populations. In an Australian study 
(n=127 cases), no association was observed between alcohol intake and cSCC except that 
the risk of cSCC was higher for patients with a history of skin cancer consuming sherry or 
port wine, which was possibly a chance finding. (19) In all these studies, alcohol intake was 
assessed only at baseline. We also had much larger sample size than these studies.
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Although epidemiological evidence on alcohol intake and cSCC is scarce, based on animal 
studies and studies on other cancers several mechanisms have been proposed to increase skin 
cancer risk in alcohol users. (20-23) The ethanol molecule is not carcinogenic (24) but 
International Agency for Research on Cancer (IARC) has classified ethanol in alcoholic 
beverages and its main metabolite acetaldehyde as Group 1 carcinogens, meaning that they 
are carcinogenic to humans. (8) Acetaldehyde is also a by-product of the fermentation 
process and present as such in many alcoholic beverages. (25) Ingested alcohol is also 
metabolized into acetaldehyde in the body. Acetaldehyde has direct carcinogenic effects in 
cells through e.g. the formation of DNA adducts which can interfere with normal DNA 
replication and mitosis in different tissues (22, 26) and by acting as a photosensitizer. (21) 
Importantly for our study, alcohol intake may increase skin cancer risk through its 
immunosuppressive effects. (23, 27) The suggested immunosuppressive mechanism may be 
especially relevant for cSCC as it is generally known that the suppression of the immune 
system increases the risk of cSCC up to 250-fold. (2, 28)
We observed an increased risk associated with consumption of white wine in our study when 
adjusted for the total average alcohol intake. White wine contains higher concentrations of 
acetaldehyde and sulfites than red wine. (25) However, it is unclear whether ingested 
acetaldehyde or sulfites have any carcinogenic activities in the skin. On the other hand, it has 
been suggested that the polyphenols, known antioxidants, in red wine may protect against 
DNA damage. (29, 30) It is also possible that the association is a result of residual 
confounding by other life-style factors or confounding by other unknown and unmeasured 
factors. Finally, these results should be interpreted with caution due to multiple testing.
There are several factors that may influence the relationship between alcohol use and skin 
cancer in observational studies. We tried to account for the confounders in our analyses and 
examine the effect modification.
In this study, the information on alcohol intake was collected before diagnosis of skin cancer 
minimizing recall bias. Furthermore, our study was conducted in three cohorts of health 
professionals who may be better aware of the harmful effects of high alcohol intake and 
therefore consume less alcohol than the general population. This would mean that the PAR 
calculated in this study may be lower than that of a general population.
We excluded participants with a history of cancer from our analyses because they are 
expected to have a different baseline risk of cSCC due to possible high-dose 
immunosuppression or radiation. We adjusted for smoking as a combined variable of (time-
dependent) smoking status and the number of pack-years.
The different dose-response curves for women and men may be explained by the fact that 
blood alcohol levels increase 10-15% in women compare to men because of the relatively 
high body fat percentage. (8) To further control for these differences in body size, we also 
adjusted for BMI in our analyses.
To our knowledge, our study was the largest prospective study of alcohol intake and cSCC. 
It is also the first longitudinal study using updated information on alcohol intake during 
follow-up (time-dependent covariates). The proportion of participants consuming alcohol 
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intake in our study was 66% at baseline, allowing meaningful comparisons between exposed 
and non-exposed to alcohol. All skin tumours were histopathologically validated and alcohol 
intake was assessed using a validated food frequency questionnaire. The participants were 
followed for on average of 19 years and detailed information was available for smoking and 
other covariates enabling us to capture changes in lifestyle during follow-up.
Our study has limitations. Although our study was the largest of its kind, the statistical 
power may still have limited to study some alcoholic beverages, especially beer in women. 
Furthermore, we cannot rule out residual confounding due to unmeasured factors.
In summary, the results of this large epidemiological study indicate that consumption of 
alcohol is associated with an increased risk of developing invasive and in situ cSCC - 
approximately 2-3% of cSCC are due to alcohol intake of 20 grams per day or more. 
Alcohol intake is a potentially modifiable life-style risk factor and, although our results are 
still to be replicated, physicians may consider counselling their patients about the association 
between alcohol consumption and risk for cSCC.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Novelty and impact of the work
Ethanol in alcoholic beverages and its main metabolite acetaldehyde are carcinogenic. 
Previous observational studies on the association between alcohol intake and cutaneous 
squamous cell carcinoma (cSCC) have been small and inconclusive. This study in three 
large cohorts suggest that each additional daily alcoholic drink is associated with 22% 
increased risk of invasive cSCC and 14% increased risk for cSCC in situ. Alcohol intake 
of ≥20 grams per day is responsible for 2-3% of all cSCC.
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Fig 1. 
Dose-response relative risk (solid line) and 95% confidence interval (dotted lines) of 
invasive cutaneous squamous cell carcinoma by alcohol intake (grams per day) for women 
and men. Model was adjusted for age, BMI, smoking status and pack-years smoked, 
physical activity, caffeine intake, family history of melanoma, tanning ability, lifetime 
number of severe sunburns, number of moles, natural hair colour, and average annual UV-B 
flux at place of residence.
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Table 1
Age-adjusted baseline characteristics of study population according to average alcohol intake categories
Characteristic Average alcohol intake, g per day
None 0.1-4.9 5.0-9.9 10.0-19.9 20.0+
NHS (female) n = 86,635 at baseline in 
1980
n=27,580 (32%) n=29,063 (34%) n=9,434 (11%) n=13,245 (15%) n=7,313 (8%)
Alcohol intake, gram per day 0.0 (0.0) 1.9 (1.2) 7.0 (1.2) 13.4 (2.5) 35.1 (12.3)
Age1, years 46.4 (7.3) 45..5 (7..3) 46.0 (7.2) 46.8 (7.0) 47.4 (6.8)
Body-mass index, kg/m2 25.3 (5.1) 24.5 (4.4) 23.7 (3.8) 23.3 (3.6) 23.3 (3.5)
Physical activity, metabolic equivalent hours 
per week
12.1 (18.3) 14.2 (20.7) 15.8 (21.1) 16.0 (22.5) 14.6 (19.0)
6+ sunburns that blistered in lifetime 6 7 9 9 10
6+ moles on left arm 5 5 5 5 4
Red or blond hair colour at age 21 15 16 16 17 17
Family history of melanoma 3 3 3 3 3
Childhood skin reaction after 2 hours in sun: 
painful burn, peel
16 14 14 13 14
Current smoker 23 27 30 35 47
Past smoker 20 29 33 35 32
Pack-years among ever-smokers 21.3 (17.0) 18.8 (15.5) 19.4 (15.8) 20.4 (16.4) 25.3 (18.6)
UVB flux at residence in 1986, erg/cm2/year 122 (25) 120 (23) 121 (24) 122 (25) 125 (26)
Caffeine intake, milligram per day 357 (278) 397 (267) 417 (264) 421 (259) 432 (259)
NHS II (female) n = 88,363 at baseline in 
1991
n=37,134 (42%) n=34,593 (39%) n=8,789 (10%) n=5,854 (7%) n=1,993 (2%)
Alcohol intake, gram per day 0.0 (0.0) 2.1 (1.2) 7.1 (1.4) 13.2 (2.4) 32.5 (12.4)
Age1, years 36.2 (4.7) 35.9 (4.7) 35.9 (4.7) 36.5 (4.7) 37.4 (4.4)
Body-mass index, kg/m2 25.5 (5.9) 24.3 (5.1) 23.3 (4.0) 23.3 (4.0) 23.5 (4.1)
Physical activity, metabolic equivalent hours 
per week
18.4 (25.1) 21.6 (27.1) 24.0 (29.9) 25.0 (29.2) 25.0 (32.0)
5+ sunburns that blistered in lifetime 9 10 11 11 12
5+ moles on lower legs 21 22 23 22 21
Red or blond hair colour at age 18 20 20 22 23 24
Family history of melanoma 4 4 5 5 5
Adolescent/childhood skin reaction after 2 
hours in sun: painful burn, peel
26 24 22 20 22
Current smoker 9 13 15 20 31
Past smoker 16 24 31 33 34
Pack-years among ever-smokers 12.9 (9.2) 11.4 (8.4) 10.9 (7.9) 11.6 (8.4) 13.1 (9.0)
UVB flux at residence in 1991, erg/cm2/year 125 (24) 123 (24) 125 (25) 127 (25) 130 (26)
Caffeine intake, milligram per day 198 (209) 254 (215) 295 (213) 317 (214) 350 (225)
HPFS (male) n = 48,140 at baseline in 
1986
n=11,237 (23%) n=11,581 (24%) n=6,987 (15%) n=9,864 (20%) n=8,471 (18%)
Alcohol intake, gram per day 0.0 (0.0) 2.5 (1.2) 7.3 (1.4) 14.2 (2.6) 39.1 (16.7)
Age1, years 54.7 (10.0) 53.6 (10.0) 53.4 (9.8) 54.3 (9.6) 55.1 (9.6)
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Characteristic Average alcohol intake, g per day
None 0.1-4.9 5.0-9.9 10.0-19.9 20.0+
Body-mass index, kg/m2 25.7 (3.6) 25.6 (3.4) 25.4 (3.3) 25.4 (3.2) 25.5 (3.2)
Physical activity, metabolic equivalent hours 
per week
18.4 (26.7) 20.1 (27.7) 22.3 (31.5) 22.8 (32.0) 22.0 (30.2)
6+ sunburns that blistered in lifetime 35 34 34 36 39
6+ moles on forearms 6 5 5 5 5
Red or blond hair colour at age 18 14 13 13 14 16
Family history of melanoma 3 3 3 3 3
Adolescent skin reaction after 1 hours in sun: 
painful burn, peel
27 26 24 24 23
Current smoker 7 8 9 10 17
Past smoker 33 41 45 50 54
Pack-years among ever-smokers 27.3 (20.8) 24.1 (18.7) 24.1 (19.0) 24.1 (18.0) 28.8 (20.5)
UVB flux at residence in 1988, erg/cm2/year 133 (28) 128 (27) 128 (27) 129 (28) 131 (28)
Caffeine intake, milligram per day 190 (227) 210 (220) 226 (217) 244 (223) 290 (238)
Values are means (SD) or percentages and are standardized to the age distribution of the study population.
1Value is not age adjusted
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